Patrick Lamy
Corporate Officer/Principal chez AKERO THERAPEUTICS, INC.
Fortune : 349 337 $ au 31/05/2024
Profil
Patrick Lamy's career history includes current and former positions as well as education.
Currently, he is the Senior Vice President-Commercial Strategy at Akero Therapeutics, Inc. Previously, he worked at Gilead Sciences, Inc. as the Head-Commercial Strategy & Banking from 2008 to 2018, and at Iovance Biotherapeutics, Inc. as the Vice President-Commercial from 2018 to 2021.
In terms of education, Mr. Lamy holds an MBA from the University of California, Berkeley, and an undergraduate degree from the University of California San Diego.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AKERO THERAPEUTICS, INC.
0,03% | 11/06/2024 | 18 562 ( 0,03% ) | 349 337 $ | 31/05/2024 |
Postes actifs de Patrick Lamy
| Sociétés | Poste | Début |
|---|---|---|
| AKERO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2023 |
Anciens postes connus de Patrick Lamy
| Sociétés | Poste | Fin |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01/02/2021 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/09/2018 |
Formation de Patrick Lamy
| University of California, Berkeley | Masters Business Admin |
| University of California San Diego | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| AKERO THERAPEUTICS, INC. | Health Technology |
| IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
